Skip to main content
SpringerLink
Log in

Interaction of Rifampicin with Bunazosin, an α1-Adrenoceptor Antagonist, in Healthy Volunteers

  • Short Communication
  • Published:
Drug Investigation Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  • Bennett PN, John VA, Whitmarsh VB. Effect of rifampicin on metoprolol and antipyrine kinetics. British Journal of Clinical Pharmacology 13: 387–391, 1982

    Article  PubMed  CAS  Google Scholar 

  • Dylewicz P, Kirch W, Santos SR, Hutt HJ, Mönig H, et al. Bioavailability and elimination of nitrendipine in liver disease. European Journal of Clinical Pharmacology 32: 563–568, 1987

    Article  PubMed  CAS  Google Scholar 

  • Herman RJ, Nakamura K, Wilkinson GR, Wood AJJ. Induction of propranolol metabolism in man by rifampicin. Pharmacologist 24: 181, 1982

    Google Scholar 

  • Hirata Y, Fukui K, Dan Y, Matsuoka H, Sugimoto T, et al. Renal and hormonal effects of α-adrenoceptor blockade by bunazosin in essential hypertension. European Journal of Clinical Pharmacology 36: 575–578, 1989

    Article  PubMed  CAS  Google Scholar 

  • Kawasaki T, Uezono K, Abe I, Nakamuta S, Ueno M, et al. Antihypertensive effect of E-643, a new alpha-adrenergic blocking agent. European Journal of Clinical Pharmacology 20: 399–405, 1981

    Article  PubMed  CAS  Google Scholar 

  • Kirch W, Rose I, Klingmann I, Pabst J, Ohnhaus EE. Interaction of bisoprolol with cimetidine and rifampicin. European Journal of Clinical Pharmacology 31: 59–62, 1986

    Article  PubMed  CAS  Google Scholar 

  • Mescheder A, Halabi A, Nokhodian A, Al-Hamdan Y, Kirch W. Antihypertensive activity, cardiac performance and pharmacokinetics of bunazosin, a novel α1-adrenoceptor antagonist, in patients with normal and impaired renal function. Drug Investigation 6: 263–270, 1993

    Article  Google Scholar 

  • Takeda N, Iwai T, Tanamura A, Nagano M. Effects of bunazosin on plasma glucose levels in hypertensive diabetic patients. Clinical Therapeutics 11: 568–571, 1989

    PubMed  CAS  Google Scholar 

  • Venkatesan K. Pharmacokinetic drug interactions with rifampicin. Clinical Pharmacokinetics 22: 47–65, 1992

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. I. Medizinische Klinik, Christian-Albrechts-Universität, Kiel, Germany

    Ali Nokhodian, Atef Halabi & Yousif Al-Hamdan

  2. Klinische Pharmakologie und Therapie, Medizinische Kliniken, Technische Universität, Fiedlerstrasse 27, D-01307, Dresden, Germany

    Ulrike Ebert &  Wilhelm Kirch

Authors
  1. Ali Nokhodian
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Atef Halabi
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Ulrike Ebert
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Yousif Al-Hamdan
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Wilhelm Kirch
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Nokhodian, A., Halabi, A., Ebert, U. et al. Interaction of Rifampicin with Bunazosin, an α1-Adrenoceptor Antagonist, in Healthy Volunteers. Drug Invest. 6, 362–364 (1993). https://doi.org/10.1007/BF03259613

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF03259613

Keywords

Search

Navigation